This paper reports the findings obtained using two new compounds belonging to the 5-nitroimidazole family: sulphuridazole (V1) and sulphonidazole (V2). We first assessed their antimicrobial activity on Clostridia spp. and then extended the study to Gram-positive and Gram-negative aerobic microorganisms and to Candida albicans. Their MICs were compared with those of metronidazole. The findings show that the antibacterial and antimycotic activity of sulphonidazole is greater than that of sulphuridazole, while metronidazole is not active against any aerobic organism. It also emerges that the NO 2 group is indispensable for all the microorganisms assayed and that sulphuridazole and sulphonidazole are the first two 5-nitroimidazoles active against C. albicans. The redox potentials of the 5-nitroimidozoles studied suggest that their action mechanism is mainly based on redox processes.
Introduction
Penicillin, which was originally used in the treatment of anaerobic infections other than Bacteroides fragilis, has now been abandoned by the majority of specialists in infectious diseases, since the microorganisms can producelactamases and so inactivate the antibiotic. [1] [2] [3] Patients can also develop an allergy to penicillin. 4 Neither clindamycin nor tetracycline is appreciably more effective against resistant strains. 5, 6 The best results are to be had using 5-nitroimidazoles; they have a heterocyclic structure consisting of an imidazole-based nucleus with a nitric radical, NO 2 , in position 5. Thanks to their bactericidal activity these chemotherapeutics inhibit the growth both of anaerobic microorganisms 7 and of certain anaerobic protozoa, such as Trichomonas vaginalis, 8, 9 Entamoeba histolytica 10 and Giardia lamblia. 11 Previously, we studied sulphimidazole, a recently synthesized molecule of sulphamidic structure with a 5-nitroimidazole nucleus bound to the amidic nitrogen of sulphanilamide. 12 The resultant sulphamide acts in synergy with trimethoprim to inhibit both aerobic and also many anaerobic bacteria of the Clostridium genus. 13, 14 For the synthesis of sulphimidazole two precursors were prepared: sulphuridazole (1-methyl-2-(methylthio)-5-nitro-1H-imidazole (V1)) and sulphonidazole (1-methyl-2-(methylsulphonyl)-5-nitro-1H-imidazole (V2)), which is obtained from sulphuridazole by oxidation of the sulphydryl group ( Figure 1 ). In the present study, the latter two compounds were assayed in vitro and compared with metronidazole in order to assess their chemotherapeutic activity against both anaerobic and aerobic bacteria. Previously it had been found that azanidazole, a 5-nitroimidazole compound, is active against many aerobic as well as anaerobic bacteria [15] [16] [17] without affecting the growth of Candida albicans. Furthermore, in order to obtain information about the mode of action, the redox potentials of the 5-nitroimidazoles studied has been carried out by electrochemical techniques.
Materials and methods

Bacterial strains and Candida spp.
All the bacteria (n 65) and the candida (n 18) used in this study were kindly donated by the Hygiene and Micro- 
Substances tested
Metronidazole was obtained from Janssen Laboratories (Rome, Italy); sulphuridazole (V1) and sulphonidazole (V2) were obtained from Proter Laboratories (Milan, Italy); 1-methyl-2-(methylthio)-1H-imidazole (V3) and 1-methyl-2-(methylsulphonyl)-1H-imidazole (V4) were synthesized in the Department of Pharmaceutical Sciences of the University of Modena (Italy) for purposes of comparison ( Figure 1 ). All the substances were dissolved in distilled water at 40-45°C and shaken mechanically.
Culture conditions
The aerobic bacteria and Clostridium spp. were cultured in tryptic soy agar and broth (Difco, Milan, Italy). All these bacteria were incubated at 37 1°C for 24 h in a normal atmosphere, but the Clostridium spp. were kept in glass jars containing an oxygen-free atmosphere for 48 h. Candida were cultured in Sabouraud broth and agar for 24 h, while for the biophotometric tests a culture-medium better suited to turbidity measurements was used, namely a liquid medium (pH 7.0) that could be sterilized in the autoclave and which was made up as follows: casamino acids (Difco), 10 g; glucose monohydrate, 10 g; sodium glycerophosphate, 2.5 g; yeast extract (Difco), 5%, 10 mL; water, to make volume up to 1 L. The use of glycerophosphate as a buffer 18 affords a clear solution after autoclaving, a necessary condition for the reading of tests dependent on turbidity. The incubation time for these tests was 24 h. Trypic soy broth (pH 7.0) was used in all the turbidity tests involving Grampositive and Gram-negative aerobic bacteria.
Susceptibility tests
The microorganisms, in a logarithmic phase of growth, were diluted with the respective sterile medium to obtain a final inoculum of about 1 10 4 cfu/0.1 mL. The MICs obtained at 24 h (for aerobes and candida) or 48 h (for anaerobes) of incubation were taken as the lowest doses at which visible growth was no longer evident. The drugs were assayed at increasing concentrations using the method of double-series scalar increments; for tests using agar the drugs were incorporated into the medium and the aerobic bacteria were placed on the agar surface using a multipoint inoculator. The growth curves of bacteria and candida were also continuously recorded for 24 h by means of a biophotometer (Bonet-Maury, France; imported by Gapel, Varese, Italy) to compare the effects of the chemotherapeutic agents. All the biophotometric tests were conducted with the instrument set at turbidity of controls at time zero.
Electrochemical experiments
Tetraethylammonium tetrafluoroborate (TEATFB; Aldrich, Milan, Italy) was used as support electrolyte as received. Dry vacuum-distilled N,N-dimethylformamide (DMF; Aldrich) was purified using sodium anthracenide in order to remove any traces of water and oxygen, according to the method of Aoyagui and co-workers. 19 The solvent was distilled via a closed system into an electrochemical cell containing the supporting electrolyte and the species under examination, shortly before performing the experiment. A potassium dihydrogen phosphate buffer, pH 7 (Riedel-de Haën, Seelze, Germany) was used as solvent in some experiments. All other chemicals were of reagent grade.
Electrochemical experiments were carried out in an air-tight, single-compartment cell described elsewhere, 20 using platinum as working and counter-electrodes and an aqueous saturated calomel electrode (SCE) as reference electrode. In the steady-state experiments, either a mercuryfilm electrode 21 or a platinum ultramicroelectrode (10 m diameter; Goodfellow, Cambridge, UK) sealed in glass was used. E 1 p,c is the one-electron peak potential for the first reduction process determined in aprotic medium (DMF) with cyclic voltammetry 22 while E 1/2 is the half wave potential obtained from the steady-state current-potential curves. 23, 24 All the potentials refer to the SCE. Voltammograms were recorded with an AMEL model 552 potentiostat controlled by an AMEL model 568 programmable function generator, an AMEL model 865 A/D converter (AMEL, Milan, Italy), a Hewlett-Packard 7475A digital plotter (Hewlett-Packard, Milan, Italy) and a Nicolet model 3091 digital oscilloscope (Nicolet, Madison, WI, USA). In the experiments with the ultramicroelectrode, a home-made high-gain potentiostat was used. 25 The minimization of the uncompensated resistance effect in the voltammetric measurements was achieved by the positivefeedback circuit of the potentiostat.
Results
We first assessed the inhibitory activity of metronidazole, V1 and V2 on eight strains of Clostridium spp.; our findings corresponded closely to those reported in the literature for 5-nitroimidazoles. We then tested to see whether, like azanidazole, they were effective against aerobic bacteria. The results reported in the Table show that, while metronidazole is completely inactive, both V1 and V2 variously inhibit bacterial growth, sulphonidazole (V2) having the lowest MIC. Although these values are too high to allow its systemic clinical use, it may well find a topical application. Given that the chemotherapeutic activity of these new compounds differs markedly from that of the majority of the better-known 5-nitroimidazoles, we set out to discover whether V1 and V2 are also active against C. albicans. The tests were carried out on 18 strains, recently isolated from pathological material and cultured in Sabouraud agar. They show that both V1 and V2 possess antimycotic properties absent in metronidazole, V2 being more potent than V1 (Table) . The graphs in Figure 2 represent the antimicrobial activity against enterotoxic E. coli and C. albicans of the various compounds used, as recorded on the biophotometer over a 24 h period: the curves confirm the findings set out in the Table. It is to be noted that the readings were not continued beyond 24 h, as the controls had achieved maximum growth. What the tests do not show, however, is whether the activity against aerobic bacteria depends on the presence and activation of the NO 2 group, as in the case of anaerobic bacteria, or on the remaining molecular moiety. Accordingly, we used two molecules analogous to V1 and V2, respectively, but lacking the NO 2 group, namely V3 and V4 (Figure 1 ). These molecules were studied biophotometrically with equimolar doses of V1 and V2. It is clear from Figure 2 that enterotoxic E. coli and C. albicans are inhibited only by molecules containing the NO 2 group with the sole exception of metronidazole; although the latter molecule contains NO 2 it is inactive against aerobic bacteria and candida.
Discussion
In the cytoplasm of anaerobic organisms there are important enzymes that make up the ferredoxin oxidoreductase complex, which is implicated in the phosphoroclastic reaction. This complex allows pyruvate to be reduced to acetate, thus enabling the cells to live without oxygen. The redox mechanisms of all anaerobes range between about 430 and 460 mV, while those of aerobes exceed 350 mV. Also, the reduction potential of metronidazole ( 415 mV) is such as to make it a better electron acceptor than the systems of anaerobic cells. When metronidazole and the other 5-nitroimidazoles enter the phosphoroclastic reaction they therefore act as electron acceptors, producing reduced intermediates with a short half-life which damage the cell and cause its death.
The principal target of the bactericidal action of 5-nitroimidazoles would appear to be the DNA, where they cause specific breaks in the adenine and thymine bases. In the composition of DNA, in terms of the relative percentages of base pairs, the anaerobes emerge as the microorganisms with the highest adenine-thymine content; accordingly, they would be most susceptible to the action of 5-nitroimidazoles. 26, 27 In line with these observations, our experimental findings show that compounds V1 and V2 are also more active against anaerobes.
In order to explain the mechanism of action of V1 and V2, the redox properties of V1 and V2, along with those of metronidazole, V3 and V4 were examined, and it was found that the cytotoxicity of 5-nitroimidazoles correlates with their electron affinity, the type of correlation depending upon the degree of the reduction of drugs. 28, 29 In particular, if the end-point chosen to assess cytotoxicity is one at which incomplete reduction has occurred, the more positive the reduction potential of the drug, the greater its cytotoxicity, but if the measurements are taken after complete reduction of the drugs, the opposite correlation is obtained, i.e. the lower the drug's electron affinity, the greater its cytotoxicity. The electron affinity of the drugs is usually expressed as E 1 7 determined in water at pH 7 by pulse radiolysis.
However, since, for a series of 5-nitroimidazoles, it has been shown that E 1 7 is linearly correlated with the oneelectron peak potential E 1 p,c for the first reduction process determined in aprotic medium (DMF) with cyclic voltammetry, 30 the electron affinity of the above 5-nitroimidazoles was measured by determining the corresponding E On the basis of these results, a satisfactory explanation of the mechanism of action of V1 and V2 in terms of their redox properties can be had. Bearing in mind that our experiments lasted 24 and 48 h for aerobic and anaerobic microorganisms, respectively, and that cytoxicity was measured as MIC, 31 the reduction of the drug should be complete. In such conditions, on the grounds of the correlations illustrated above, the more negative the redox potential of the drug, the greater its cytoxicity would be expected to be. The data reported in the Table are in good agreement with this prediction. In fact, in the case of the aerobes, it is evident that, while the cytotoxicity of V1 is similar to that of 5-nitroimidazoles, since their reduction potentials are substantially similar, the cytotoxicity of V2 is significantly higher than that of metronidazole, which reflects the fact that its reduction potential is much more negative than that of metronidazole. Also, that all three 5-nitroimidazoles are more cytotoxic for anaerobes than for aerobes is in line with the fact that the range of potentials of the redox mechanisms of anaerobes is more negative than that of aerobes. With anaerobes, however, the rather greater toxicity observed with respect to aerobes could explain the similarity of the behaviour of the three 5-nitroimidazoles. The behaviour of V3 and V4 also bears out the notion that the main mechanisms of action should be based on redox processes; indeed, their biological inactivity can be explained by the electro-inactivity, which coincides with the absence of the NO 2 group in their structure.
It must be mentioned that similar conclusions regarding the mechanism of action can be reached if account is taken of the electrochemical behaviour of V1, V2, V3, V4 and metronidazole in aqueous solutions at pH 7. In this case, however, less experimental information can be obtained, since, owing to the potential window explorable being more restricted than it is in the aprotic medium, only the reduction processes relative to V1 and metronidazole can be observed. In particular, in aqueous medium the reduction potential of V1 is similar to that of metronidazole, albeit slightly more positive (E 1/2 0.70 and 0.60 V for V1 and metronidazole, respectively), and the two 5-nitroimidazoles can therefore be expected to possess similar cytotoxicity, as borne out by the experimental findings. Regarding the cytotoxicity of V2, the absence of a reduction process before the discharge of the buffered solution (about 1.5 V) prevents the reduction potential being used to obtain precise information about its cytotoxicity. Nevertheless, its electro-inactivity, at least up to the discharge of buffered solution, which makes the reduction potential of an eventual electrode process much more negative than that of metronidazole, is consistent with its being more cytotoxic than metronidazole. Analogous considerations can be made with reference to V3 and V4.
The above discussion shows clearly the advantage of carrying out electrochemical studies in aprotic rather than aqueous media in order to obtain information about struc- ture-cytotoxity relationships. Besides the mechanism based on redox processes, other mechanisms could be operative in our conditions. In particular, the fact that the two new 5-nitroimidazoles are generally more cytotoxic than metronidazole could be due to the presence of the C-S bond in position 2. This would agree with the hypothesis put forward by Winkelmann and co-workers, according to whom the presence of the C-S bond would represent an 'ideal' combination of transport across the cell membranes and active form of nitroimidazoles. 32 To conclude, although these two new 5-nitroimidazoles have higher MICs for aerobes than for anaerobes, we feel that they can be the starting point for studies into new compounds with enhanced antibacterial and antimycotic properties.
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